ڷγ19 ġ ӻ Ȳ ('20.09.02.) - ӻ 17 ࡦġ 15 2 -
ó: ǰǾǰó Link
ǰǾǰó(ǰ ó) ڷγ19 ġ Ȱ ǰ ִ , ǰ ִ ġ ӻ 㰡ɻ Ȳ Ѵٰ ϴ.
< ġ ӻ Ȳ > , ε ӻ 22(ġ 20, 2)Դϴ. ġ ӻ 5 *Ǿ ӻ 17(ġ 15, 2)Դϴ. * ú 3 ũθĮƮ, ҷϽ 1 δ ü ϰ ִ ӻ 12̸, ϴ ӻ 5Դϴ. - ü ϴ ӻ , 7 2 ӻ( ȹġ ), 5 1 ӻ(Ʈ üġ, DNA )Դϴ.
|
|
|
| ǰз | ġ | 20 | 15 | 5 |
| 2 | 2 | - | հ | 22 | 17 | 5 | ӻü |
ü | 1 | ġ 3, 2 | 5 | - | 2 | ġ 7 | 7 | - | 3 | ġ 2 | - | 2 |
| ġ 8 | 5 | 3 | հ | 22 | 17 | 5 |
ӻ ܰ | | (ӻ 1) Ͽ , ൿ (ӻ 2) 1 , ȯڵ鿡 Ͽ ġȿ Ž (ӻ 3) 2 , ȯ鿡 Ͽ ġȿ Ȯ 1 2(1/2) Ǵ 2 3(2/3) ϴ 쵵 |
< ġ Ȳ > ȹġ üġ Ȳ Ʒ ϴ. ȹġ 8 20 2 ӻ ι, Zﺴ 6 9 ڷγ19 7 ̳ ȯڸ ӻ* ǽ Դϴ. * Ȯε ȯ, 70 ̻ 60 ̻ ȯڸ ġῡ ߰ ȹġ 뷮 15
Ʈ ȭüġ ž(CT-P59) ǰ ӻ 1 ϷǾ, 2/3 ӻ ȹ ɻ ߿ ֽϴ. - Ʈ ȯ 1 ӻ ι ȯڸ ϰ ֽϴ.
< ڷγ19 ż Ͻ > ľó ڷγ19 ʿ , ̸ غ 20% 3õ ǥ ż Ͻ Դϴ. - ̸ Ǵ 9 22 2õ 6鸸 ̻ ȹԴϴ.
ľó ڷγ19 ġ ӻ ϰ, ̸ ʿ ǰ㰡, Ưʼ Ͽ 츮 ġ ȸ ֵ ּ ϰڽϴ.
<÷> ڷγ19 ӻ Ȳ(2020.8.31. )
|
| Ƿ | ǰ | ӻ | ܰ |
| ġ | 1 | 渮̾ڸ ȸ | ú | COVID-19 ڿ ú(GS-5734) ̷ Ȱ ϱ 3 [] | 3 | 2020-03-02 | 2 | 渮̾ڸ ȸ | ú | ߵ COVID-19 ڿ ǥ ġ ú(GS-5734) ̷ Ȱ ϱ 3 [] | 3 | 2020-03-02 | 3 | б | ú | COVID-19 remdesivir ȿ ٱ, , ߴ, [] | ӻ | 2020-03-05 | 4 | ܹξƻȸܼƻ꺴 | ĮƮ, ũθ | ڷγ19 ȯڿ lopinavir/ritonavir vs hydroxychloroquine vs ౺ open labelled randomized controlled clinical trial [] | ӻ | 2020-03-20 | 5 |
| ҷϽ | SARS -CoV -2 μ ̵ϽŬθ [] | ӻ | 2020-03-25 | 6 | б κ | ˺ | ڷγ19 ȯڿ Ciclesonide ӻ ȿ | ӻ | 2020-03-27 | 7 | αǰ | ĸ30mg (Ŭε) | ߵ ڷγ̷-19(COVID-19) ȯڿ Ŭε (Clevudine) ȿ ϴ ϸͰ, , , ٱ 2 ӻ | 2 | 2020-04-14 | 8 | б | ź (ĸŸƮ) | ڷγ19 ȯڿ Nafamostat mesilate ġȿ м , , ӻ | ӻ | 2020-04-17 | 9 | ƴб | ε | COVID-19 ȯ ɿ ε 28 2a , ֵ | ӻ | 2020-04-21 | 10 | | EC-18 | ڷγ̷ ȯڿ EC-18 ȿ ϱ ٱ, , 2 ӻ | 2 | 2020-05-12 | 11 | dz | Ƕƽ | Ǵ ߵ ڷγ̷-19 (COVID-19) ȯڸ Ƕƽ ȿ ϱ ٱ, , ߴ, , , 2 ӻ | 2 | 2020-05-13 | 12 | б | ٸƼ | COVID-19 ο ȿ ٱ, , ߴ, | ӻ | 2020-05-18 | 13 | ٴ | CKD-314 (ĸŸƮ) | ڷγ 19 ܹ Կ ȯ CKD-314 ȿ ϱ , ٱ, , ġ Ž 2 ӻ | 2 | 2020-06-17 | 14 | ũŻͽ | CG-CAM20 (īŸƮ) | ڷγ19 ̷ (SARS CoV 2) Ȯ COVID-19 ȯڿ īŸƮ(Camostat) ġ ȿ ϱ , , , 2 ӻ | 2 | 2020-07-01 | 15 |
| DW1248 (īŸƮ) | ߵ ڷγ19 ȯڸ DWJ1248 ȿ ϱ ߴ, , , ٱ 2 ӻ | 2 | 2020-07-06 | 16 | Ʈ | CT-P59 | ǰ ڸ CT-P59 , ༺ ൿ ϴ 1, , ߴ, , ౺, ȸ 뷮 ӻ | 1 | 2020-07-17 | 17 | б | Rebif () | COVID-19 ο ȿ ٱ, , ߴ, | ӻ | 2020-08-04 | 18 | ؽ | GX-I7 (ͷŲ) | ڷγ̷ (COVID-19) ȯڿ GX-I7 ȿ Ž 1b ӻ | 1b | 2020-08-07 | 19 |
| GC5131 (ȹġ) | COVID-19 ȯڿ H-Ig(鿪۷κҸ) GC5131 뷮 ȿ, ϱ , , , ٱ 2 ӻ | 2 | 2020-08-20 | 20 | Ʈ | CT-P59 | ڷγ-19 ̷ (SARS-CoV-2) ִ ڿ CT-P59 , ༺ ̷ ϴ 1, , , , ౺, Ͽ뷮 | 1 | 2020-08-25 |
| 1 | ſ | INO-4800 | ǰ dz (Intradermal, ID) õ(Electroporation, EP) ̿ϴ SARS-CoV-2 INO-4800 , ༺ 鿪 ϱ 뷮 , 1/2a ӻ | 1/2a | 2020-06-02 | 2 | ()ؽ | GX-19 | ǰ COVID-19 DNA GX-19 , ༺ 鿪 Žϱ ٱ, , , , 1/2a ӻ | 1/2a | 2020-06-11 |
|
|